Compare Edwards Lifesciences Corporation Common Stock (EW) vs IONQ Inc (IONQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs IONQ Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while IONQ Inc trades at $40.32 (market cap $16.75B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 3× IONQ Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| EW | IONQ | |
|---|---|---|
Market Cap | $49.44B | $16.75B |
Volume | 3,508,027 | 18,768,450 |
Sector | Health | Technology |
52-Week High | $95.18 | $82.09 |
52-Week Low | $72.65 | $26.59 |
Enterprise Value | $45.90B | $14.68B |
Typical Hold Time | — | 33 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IONQ trades at $41.34, down 4.5% today, with a mixed technical picture showing bullish oscillators but bearish moving averages. The company reported strong revenue growth to $130M in 2025 but faces significant losses with a -553% net income margin. Recent analyst coverage from Bank of America initiated with a Buy rating and $60 target, highlighting the company's semiconductor-based quantum computing approach and partnerships with major cloud providers.
While IONQ shows promising technology and analyst support with a consensus $62.75 price target representing 52% upside, investors face substantial risks from ongoing losses, negative cash flow from operations, and high valuation multiples. The stock's performance hinges on successful commercialization of quantum technology and achieving profitability targets in the coming years.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →
